Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.57 -0.65 (-3.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Sarepta Therapeutics' Depreciation & Amortization (CF) was $10.41 million in Q2 2026, down 4.0% from $10.84 million a year earlier and down 1.7% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Sarepta Therapeutics' Depreciation & Amortization (CF) was $44.71 million through Jun 30, 2026, up 8.8% year-over-year; for FY2025, it came in at $44.52 million, up 18.0% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $37.72 million in FY2024 (-15.0%), $44.4 million in FY2023 (+6.1%), $41.86 million in FY2022 (+10.1%) and $38.02 million in FY2021 (+41.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $5.25 million (Q4 2025) and $18.45 million (Q3 2025) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last eight quarters, with growth averaging 7.6%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2025 (growth of 88.2%); the worst was Q4 2025 (a decline of 49.8%).
  • Per Business Quant data, SRPT's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $10.59 million (Q1 2026), $5.25 million (Q4 2025) and $18.45 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Sarepta Therapeutics 1.92 Bn -1.31 Bn 251.87 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.41 Mn
Mar 31, 2026 10.59 Mn
Dec 31, 2025 5.25 Mn
Sep 30, 2025 18.45 Mn
Jun 30, 2025 10.84 Mn
Mar 31, 2025 9.98 Mn
Dec 31, 2024 10.46 Mn
Sep 30, 2024 9.81 Mn
Jun 30, 2024 8.72 Mn
Mar 31, 2024 8.74 Mn
Dec 31, 2023 11.37 Mn
Sep 30, 2023 10.93 Mn
Jun 30, 2023 10.79 Mn
Mar 31, 2023 11.31 Mn
Dec 31, 2022 10.55 Mn
Sep 30, 2022 10.70 Mn
Jun 30, 2022 9.89 Mn
Mar 31, 2022 10.72 Mn
Dec 31, 2021 10.15 Mn
Sep 30, 2021 10.50 Mn
API Access

Sarepta Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SRPT&period=max&api_key=YOUR_API_KEY